ALFA FinderNSE filing, NSE: ZYDUSLIFE. Summary written from the filing by ALFA Finder's alert engine.
Zydus Lifesciences Ltd: key numbers
- Share price
- ₹1,197.90
- Market cap
- ₹1,20,537 Cr
- Revenue (annual)
- ₹27,148 Cr
- Net profit (annual)
- ₹5,040 Cr
- P/E (TTM)
- 28.8×Sector 43.0×
- Promoter holding
- 75.01%+0.00% QoQ
- FII holding
- 7.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zydus Lifesciences Ltd
All →Zydus Lifesciences Capital Structure Change
LIC sold 20,242,068 Zydus Lifesciences shares via market sale, cutting its stake from 5.21 percent to 3.18 percent. Non-promoter SAST disclosure covering 28.08.2025 to 05.11.2026.
Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Zydus Lifesciences Earnings Call Transcript: Key Takeaways
Consolidated revenue ₹7,910 Cr (+29% YoY), EBITDA margin 24%, net profit ₹930 Cr. Growth partly acquisition-led. Saroglitazar launch spend is heavy and the US launch is targeted for March 2027.
Zydus Lifesciences Results Update
Zydus Lifesciences reported Q2 FY27 revenue of Rs. 79,096 mn, up 29% y-o-y. H1 net profit was Rs. 18,859 mn, down 31%.
Zydus Lifesciences Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 7,910 Cr (+29% YoY), EBITDA Rs 1,895 Cr at 24.0% margin, reported PAT Rs 926 Cr (-26.6% YoY). Branded India and North America drove growth; FX and D&A weighed on profit.
Zydus Lifesciences Other Announcement
Zydus Lifesciences board approved appointment of Walker Chandiok & Co LLP as statutory auditors for a five-year term. This follows mandatory rotation of outgoing auditor Deloitte Haskins and Sells LLP.
Other promoter buying (off-market) announcements
All →Amanta Healthcare Promoter Buying (Off-Market): ₹5.4 Cr
Promoter Jitendrakumar Patel bought 3,00,150 Amanta Healthcare shares off-market for about Rs 5.40 Crore. Promoter holding rises from 9.02% to 9.79%.
- Value
- ₹5.40 Cr
- Promoter stake change
- +0.77%
Advit Jewels Promoter Buying (Off-Market)
Abhishek Gilara received 77.78 lakh Advit Jewels shares from brother Vipul Gilara via an inter-se gift. The acquirer's holding rises to 16.98%, with no consideration paid.
- Promoter stake change
- +16.98%
Axita Cotton Promoter Buying (Off-Market)
Gitaben Patel, a promoter group member, will acquire 3,98,70,411 Axita Cotton shares (10.42%) as a gift from relative Kushal Patel. Her stake rises from 3.33% to 13.75%.
- Promoter stake change
- +10.42%
Jindal Hotels Promoter Buying (Off-Market)
Piyush D. Shah, promoter and MD of Jindal Hotels, acquired 1,31,368 shares (1.88%) by way of gift on 04.11.2026, raising his holding to 19%. The filing is a Reg 29(2) SAST disclosure of an off-market promoter transfer.
- Promoter stake change
- +1.88%
AVI Products India Promoter Buying (Off-Market)
PPMS Real Estates LLP, AVI Products' promoter, shifted partner stakes internally; Parthh Mehta fell from 99% to 96.76%. Its 62.83% direct holding in AVI is unchanged.
Inox India Promoter Buying (Off-Market)
Shreyasi Goenka disclosed a Reg 10(1)(a)(i) inter-se gift of 18,18,449 INOX India shares (2.00%) from Pavan Kumar Jain, with no consideration. The transfer is among immediate promoter relatives, so no open offer is triggered.
- Promoter stake change
- +2.00%